Cargando…
PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705897/ https://www.ncbi.nlm.nih.gov/pubmed/26625219 http://dx.doi.org/10.1038/bjc.2015.388 |
| _version_ | 1782409099673075712 |
|---|---|
| author | Black, Jonathan D Lopez, Salvatore Cocco, Emiliano Bellone, Stefania Altwerger, Gary Schwab, Carlton L English, Diana P Bonazzoli, Elena Predolini, Federica Ferrari, Francesca Ratner, Elena Silasi, Dan-Arin Azodi, Masoud Schwartz, Peter E Santin, Alessandro D |
| author_facet | Black, Jonathan D Lopez, Salvatore Cocco, Emiliano Bellone, Stefania Altwerger, Gary Schwab, Carlton L English, Diana P Bonazzoli, Elena Predolini, Federica Ferrari, Francesca Ratner, Elena Silasi, Dan-Arin Azodi, Masoud Schwartz, Peter E Santin, Alessandro D |
| author_sort | Black, Jonathan D |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4705897 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47058972016-01-28 PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas Black, Jonathan D Lopez, Salvatore Cocco, Emiliano Bellone, Stefania Altwerger, Gary Schwab, Carlton L English, Diana P Bonazzoli, Elena Predolini, Federica Ferrari, Francesca Ratner, Elena Silasi, Dan-Arin Azodi, Masoud Schwartz, Peter E Santin, Alessandro D Br J Cancer Corrigendum Nature Publishing Group 2015-12-01 2015-12-01 /pmc/articles/PMC4705897/ /pubmed/26625219 http://dx.doi.org/10.1038/bjc.2015.388 Text en Copyright © 2015 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ |
| spellingShingle | Corrigendum Black, Jonathan D Lopez, Salvatore Cocco, Emiliano Bellone, Stefania Altwerger, Gary Schwab, Carlton L English, Diana P Bonazzoli, Elena Predolini, Federica Ferrari, Francesca Ratner, Elena Silasi, Dan-Arin Azodi, Masoud Schwartz, Peter E Santin, Alessandro D PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas |
| title | PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas |
| title_full | PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas |
| title_fullStr | PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas |
| title_full_unstemmed | PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas |
| title_short | PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas |
| title_sort | pik3ca oncogenic mutations represent a major mechanism of resistance to trastuzumab in her2/neu overexpressing uterine serous carcinomas |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705897/ https://www.ncbi.nlm.nih.gov/pubmed/26625219 http://dx.doi.org/10.1038/bjc.2015.388 |
| work_keys_str_mv | AT blackjonathand pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT lopezsalvatore pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT coccoemiliano pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT bellonestefania pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT altwergergary pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT schwabcarltonl pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT englishdianap pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT bonazzolielena pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT predolinifederica pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT ferrarifrancesca pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT ratnerelena pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT silasidanarin pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT azodimasoud pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT schwartzpetere pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas AT santinalessandrod pik3caoncogenicmutationsrepresentamajormechanismofresistancetotrastuzumabinher2neuoverexpressinguterineserouscarcinomas |